[go: up one dir, main page]

AR012636A1 - ASK 3.20 DIOLES, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents

ASK 3.20 DIOLES, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT

Info

Publication number
AR012636A1
AR012636A1 ARP980102022A ARP980102022A AR012636A1 AR 012636 A1 AR012636 A1 AR 012636A1 AR P980102022 A ARP980102022 A AR P980102022A AR P980102022 A ARP980102022 A AR P980102022A AR 012636 A1 AR012636 A1 AR 012636A1
Authority
AR
Argentina
Prior art keywords
manufacture
pharmaceutical composition
dioles
understands
ask
Prior art date
Application number
ARP980102022A
Other languages
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR012636A1 publication Critical patent/AR012636A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pregnanos 3,20 dioles que contienen la formula (I) en la cual R y R1 son cada uno, independientemente, hidrogeno o SO3X+; X+ es metal alcalino, metalalcalinotérreo, amonio, alquilamonio que contiene 1-6 átomos de carbono o dialquilamonio quecontiene 1-6 átomos de carbono en cada grupo alquilo otrialquilamonio que contiene 1-6 átomos de carbono en cada grupo alquilo; con la condicion de que R Y R1 no sean ambos hidrogeno, que es util como un agentepregestacional; composicion farmacéutica que los comprende y su uso en la fabricacion de un medicamento.Give us 3.20 diols containing formula (I) in which R and R1 are each, independently, hydrogen or SO3X +; X + is alkali metal, metal alkaline earth metal, ammonium, alkyl ammonium containing 1-6 carbon atoms or dialkylammonium containing 1-6 carbon atoms in each alkyl group or otyalkyl ammonium containing 1-6 carbon atoms in each alkyl group; with the proviso that R and R1 are not both hydrogen, which is useful as a pre-pregnancy agent; pharmaceutical composition comprising them and their use in the manufacture of a medicine.

ARP980102022A 1997-05-02 1998-04-30 ASK 3.20 DIOLES, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AR012636A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85087697A 1997-05-02 1997-05-02

Publications (1)

Publication Number Publication Date
AR012636A1 true AR012636A1 (en) 2000-11-08

Family

ID=25309349

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102022A AR012636A1 (en) 1997-05-02 1998-04-30 ASK 3.20 DIOLES, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT

Country Status (11)

Country Link
EP (1) EP0980384A1 (en)
JP (1) JP2001523268A (en)
KR (1) KR20010012156A (en)
CN (1) CN1254343A (en)
AR (1) AR012636A1 (en)
AU (1) AU7165898A (en)
BR (1) BR9809380A (en)
CA (1) CA2289095A1 (en)
TW (1) TW434017B (en)
WO (1) WO1998050415A1 (en)
ZA (1) ZA983702B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895103A (en) * 1971-11-22 1975-07-15 Alza Corp Intrauterine contraceptive device containing certain pharmaceutically acceptable steroids
WO1993005786A1 (en) * 1991-09-13 1993-04-01 Cocensys, Inc. Novel gabaa receptor with steroid binding sites

Also Published As

Publication number Publication date
WO1998050415A1 (en) 1998-11-12
KR20010012156A (en) 2001-02-15
CA2289095A1 (en) 1998-11-12
TW434017B (en) 2001-05-16
CN1254343A (en) 2000-05-24
EP0980384A1 (en) 2000-02-23
ZA983702B (en) 1999-11-01
AU7165898A (en) 1998-11-27
BR9809380A (en) 2000-07-04
JP2001523268A (en) 2001-11-20

Similar Documents

Publication Publication Date Title
BR0007781A (en) Physiologically active conjugate, composition, and, process for the production of a peg-gcsf conjugate
TR200102800T2 (en) New compounds.
ES2083368T3 (en) USE OF HALOGENATED HYDROCARBON SOLVENTS AS CLEANING AGENTS.
IL123293A0 (en) Piperidine derivatives their preparation and use
ES2052629T3 (en) PIRAZOLO (3,4-D) PIRIDINES, PROCEDURE FOR ITS PREPARATION AND USE AS MEDICINES.
ES2071681T3 (en) MACROCYCLE COMPOUNDS.
BRPI9917007B8 (en) azabicycloalkanes as ccr5 modulators, pharmaceutical composition containing them, as well as their use
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
GR3034204T3 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
SE9702001D0 (en) Novel compounds
ES2126766T3 (en) TROPYL 7-AZAINDOL-3-ILCARBOXIAMIDES AS ANTI-TUSSIVE AGENT.
BR0011521B8 (en) 4-c-ethinyl purine nucleoside compounds
BR0010940A (en) Coating material with a mixture of at least one wetting agent and urea and / or urea derivatives as thixotropic agents
ATE33103T1 (en) MICROCAPSULES WHICH RELEASE IS CONTROLLED LONG-TERM.
TR200201102T2 (en) New oligosaccharides, their preparation and drug compositions containing them
CA2040982A1 (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
ES468525A1 (en) 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
ES476117A1 (en) Steroid cyanoketones and intermediates
ES2145129T3 (en) DERIVATIVES OF BENZOPYRAN AND BENZOXAZINE.
BR9711647A (en) New derivatives of Dicafeoilquímica, their use, compositions with them and treatment methods using them.
ES2060709T3 (en) DERIVATIVES OF PIRIDILO AND PIRIMIDILO.
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
MX9303990A (en) TETRAZOLIL (FENOXI AND FENOXIALQUIL) PIPERIDINIL PIRIDAZINAS AS ANTIVIRAL AGENTS.
AR012636A1 (en) ASK 3.20 DIOLES, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
ES8608884A1 (en) A PROCEDURE FOR ELIMINATION OF THE VIRUS LAV.